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Abstract:    23 
Background and objectives: Airway clearance techniques (ACTs) are commonly 24 
prescribed for patients experiencing acute exacerbations of chronic obstructive 25 
pulmonary disease (AECOPD), however large variability in practice is commonly 26 
observed. This study aimed to explore current physiotherapy practice regarding 27 
ACTs for people with AECOPD in the Republic of Ireland.    28 
Method: A cross-sectional online survey using multiple-choice questions and Likert 29 
scales was distributed to 202 physiotherapy clinicians via direct email and the Irish 30 
Society of Chartered Physiotherapists. Main survey themes included use of ACTs in 31 
relation to effectiveness and ease of use, and awareness of the literature and 32 
guidelines.  33 
Results: Seventy responses (35%) were received. The majority of respondents (n= 34 
56, 80%) reported prescribing ACTs for more than 60% of patients with AECOPD 35 
with the most common techniques being physical activity (n=65, 93%) and active 36 
cycle of breathing techniques (n=53, 90%). Sputum management (n= 66, 94%) was 37 
the most commonly reported indicator for use of ACTs. The majority of 38 
physiotherapists (n=42, 60%) reported being unsure of the literature or finding it 39 
conflicting regarding ACTs in AECOPD.    40 
Conclusion: Physiotherapists in ROI regularly prescribe ACTs for patients with 41 
AECOPD despite a considerable reported lack of awareness of the evidence 42 
regarding their effectiveness. Further research is required to determine the reasons 43 
for this.    44 
Key words; exacerbation, chronic obstructive pulmonary disease, sputum, airway 45 
clearance techniques, physiotherapist    46 
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Introduction and background;   67 
Chronic obstructive pulmonary disease (COPD) is a progressive, irreversible lung 68 
disease typically caused by exposure of the airways to noxious substances [1]. It is 69 
defined physiologically by a persistent obstructive airflow defect, and characterised 70 
by symptoms of breathlessness, cough and sputum production [1]. COPD is the third 71 
leading cause of death in the world and accounts for 6% of deaths internationally [2]. 72 
It is speculated almost 500,000 people (~10% of the population) in the Republic of 73 
Ireland (ROI) could have COPD, with almost half of that figure likely to have 74 
moderate to advanced disease [3]. Acute exacerbations of COPD (AECOPD) involve 75 
acute deterioration of respiratory symptoms beyond normal day-to-day variability that 76 
require supplemental therapy [2]. Signs of AECOPD may include productive cough, 77 
increased sputum production, change in sputum colour and increased 78 
breathlessness [4].  79 
In healthy lungs, secretions are cleared via cephalad transportation of mucus by cilia 80 
in the lining of the airways. This is recognised as an innate immuno-defence 81 
mechanism to protect against adverse effects of foreign particles [6]. In COPD, 82 
however, excess sputum and airways secretions are pathological disease 83 
components [7] that negatively impact upon this process, with cough and sputum 84 
linked to increased frequency of exacerbations and hospitalisation [5]. The presence 85 
of an abnormal defence mechanism to protect against excessive airway secretions 86 
justifies a role for supportive management strategies that aim to promote secretion 87 
clearance. Airway clearance techniques (ACTs) are techniques that aim to clear 88 
secretions via use of gravity, breath holding, forced expiratory technique and/or 89 
positioning, leveraging on key principles of alveolar interdependence and collateral 90 
ventilation [8]. Alveolar interdependence allows air to move into the smaller airways 91 
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while expanding alveoli exert traction to surrounding poorly inflated alveoli [8]. When 92 
peripheral airways are obstructed, collateral ventilation provides alternative routes (in 93 
the form of channels) for air to flow [9]. In the literature, ACTs have been proposed to 94 
improve airflow to collateral channels and influence alveolar interdependence [9], 95 
however supportive evidence has proven challenging to emerge [10].   96 
Evidence of clinical effectiveness regarding ACTs for people with AECOPD has 97 
existed for some time now, however conclusions in relation to the most effective 98 
ACTs are variable [11]. This is likely due to considerable heterogeneity of review 99 
methodologies and highly variable quality of individual clinical trials [7,10,12,13]. A 100 
small number of studies have explored physiotherapy practice of ACT prescription 101 
for the management of patients with AECOPD [15-19], demonstrating large 102 
variability in practice. For example, the most prescribed techniques in Australia were 103 
ACBT and physical exercise [18], while Swedish physiotherapists reported using 104 
PEP masks most [19]. No data exists relating to ROI.   105 
In the ROI, use of ACTs by physiotherapists for COPD is outlined by the Health 106 
Services Executive (HSE) “End to End COPD Model of Care” clinical guidelines, 107 
which are based on the Global Initiative for Obstructive Lung Disease (GOLD) 108 
Guidelines [2, 3]. The HSE recommends use of ACTs by physiotherapists treating 109 
patients with COPD in the integrated care, acute hospital and COPD outreach 110 
settings but does not specify which ACTs are most effective or how to prescribe 111 
them.   112 
The primary aim of the study was to determine current practice of physiotherapists 113 
with respect to ACTs and AECOPD in the ROI. Secondary aims were to explore 114 
perceptions of importance and effectiveness of ACTs, to identify factors influencing 115 
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the prescription of ACTs and to examine physiotherapists awareness of evidence for 116 
ACTs in their management of AECOPD.   117 
 118 
Methods   119 
Procedures  120 
A cross-sectional survey of physiotherapists treating patients with AECOPD in the 121 
ROI was implemented during January and February of 2020. The survey was 122 
conducted electronically via Survey Monkey due to clinicians’ familiarity with the 123 
approach and to facilitate timely completion. Physiotherapists working in the ROI in 124 
the public or private health system were eligible for inclusion if they were registered 125 
with (or pending registration with) the national professional body CORU, and had 126 
treated patients with AECOPD within the last 10 years. For the purpose of this study 127 
an AECOPD was defined as an acute deterioration of a patients’ respiratory 128 
symptoms requiring supplemental therapy [2], either in the community or following 129 
hospital admission. ACTs were defined as techniques used by a physiotherapist for 130 
the purpose of clearing sputum from patients’ airways [18].   131 
The survey comprised multiple-choice questions and Likert scales, based upon a 132 
previously used instrument [18, 19], with alteration of one question and addition of 133 
one other. The survey was reviewed by a respiratory clinical nurse specialist, a 134 
senior physiotherapist and a respiratory consultant physician in ROI to verify 135 
questions were appropriate for target respondents. Permission was granted to 136 
distribute the survey via email link to members of the Chartered Physiotherapists in 137 
Respiratory Care group (90 physiotherapists) and Chartered Physiotherapists 138 
Manager group (88 physiotherapy managers) of the Irish Society of Chartered 139 
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Physiotherapists (professional body of the ROI). The survey was also emailed to 140 
physiotherapists throughout the ROI working in COPD outreach and respiratory 141 
integrated care services (approximately 24 physiotherapists), with all recipients 142 
encouraged to share the survey with colleagues experienced in respiratory care. In 143 
total, the approximate number of survey distributions was 202. To facilitate survey 144 
engagement, potential participants were emailed one week prior to initial survey 145 
distribution and reminders sent one, two and three weeks afterwards. Survey 146 
responses were also anonymised and data pertaining to work location and education 147 
history were not recorded. Ethical approval for the study was granted by Ulster 148 
University Ethics Board in December 2019.  149 
Data analysis  150 
Data were presented descriptively using frequencies, and percentages. Some data 151 
were pooled into fewer categories in order to explore relationships between 152 
variables. For example, work experience in the cardiorespiratory field was 153 
subdivided as ≤5 vs 5 or more years, and similar approaches used for perceived 154 
effectiveness and awareness of the evidence regarding ACTs. Statistical significance 155 
was set at p ≤0.05. Analyses were conducted using IBM SPSS statistical package 156 
version 26 and results presented as column graphs via Microsoft Excel.    157 
Results   158 
Participants   159 
Responses were received from 70/202 (35% response rate) physiotherapists who 160 
self-reported meeting study inclusion criteria. The majority of respondents (n=59, 161 
84%) reported greater than 5 years experience, with 63% (n=44) working in cardio-162 
respiratory physiotherapy for at least 10 years. As survey responses were 163 
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anonymised, data pertaining to workplace (public, private, community or hospital 164 
based) were not included.  165 
Current practice   166 
The majority of respondents (n= 56, 80%) reported prescribing ACTs for more than 167 
60% of patients with AECOPD with only 7% (n= 5) doing so rarely or never. The 168 
number of years working in cardiorespiratory did not appear to influence frequency of 169 
prescription of ACTs for patients with AECOPD (p= 0.65). The majority of 170 
respondents (n=65, 92%) spent between 5-20 minutes on ACT treatment, with 3% 171 
(n=2) spending 0-5 minutes, 40% (n=28) spending 5-10 minutes, 31% (n=22) 172 
spending 10-15 minutes and 21% (n=15) spending 15-20 minutes. 96% (n=69) of 173 
respondents felt that ACTs were important (very important, fairly important or 174 
moderately important). The most commonly prescribed individual ACTs (combined 175 
“very often/always” or “often”) were physical activity 93% (n=65), ACBT 90% (n=63) 176 
and deep breathing exercises 90% (n=63). A detailed overview of all ACTs is 177 
presented in Figure 1.   178 
Perceptions    179 
Physiotherapists perceived the most effective techniques for clearing sputum (very 180 
effective/ effective) to be physical activity (n=66, 94%), followed by ACBT (n=63, 181 
90%), oscillating PEP (n=62, 89%) and directed huffing (n=60, 86%). With respect to 182 
patient mastery of ACTs, respondents perceived physical activity (n=61, 87%), deep 183 
breathing (n=61, 86%) and ACBT (n=52, 74%) to be easiest (very easy/easy). There 184 
was no statistically significant relationship between perceived importance of 185 
ACTs  and years of experience working in cardiorespiratory physiotherapy (p= 186 
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0.439). Frequency of use, perceived effectiveness and perceived ease of patients’ 187 
mastery of airway clearance techniques is summarised in Figure 1.    188 
Clinical reasoning   189 
The most frequently identified indicators for prescribing ACTs were “difficulty 190 
managing secretions” (n=67, 96%) and “recent change in sputum characteristics” 191 
(n=63, 90%) (Figure 2). The vast majority of respondents reported their primary aim 192 
of prescribing ACTs was “to clear sputum” (n=68, 97%), “to improve oxygenation” 193 
(n=59, 84%), “enhance recovery from AECOPD” (n=57, 81%) and “improve quality of 194 
life” (n=53, 76%). Physiotherapists’ reasoning for choosing between different ACTs 195 
was made on the basis of those deemed “easiest to master” (n=51, 73%), followed 196 
by “access to resources/equipment” (n=45, 64%), “degree of dyspnoea” (n=42, 60%) 197 
and “patient preference” (41/70, 59%).    198 
Knowledge of literature and guidelines   199 
While 40% (n=28) of respondents believed there was evidence supporting the use of 200 
ACTs during AECOPD, 40% (n=28) believed the evidence was “conflicting, 201 
inconclusive or non-existent to support or refute use of ACTs”. Twelve respondents 202 
(20%) declared feeling “unsure what the current evidence is”. Of the 80% of 203 
respondents who felt they were familiar with the literature, no differences were 204 
evident in terms of the extent of their experience between those working in 205 
cardiorespiratory more or less than 5 years and their awareness of the evidence for 206 
the effectiveness for ACTs with AECOPD (p = 0.534). There was also no significant 207 
relationship between respondents who felt ACTs were important in the management 208 
of patients with AECOPD and perception of the strength of evidence to support the 209 
practice of ACTs for patients with AECOPD (p = 0.377). Fifty (71%) respondents 210 
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indicated they were not familiar with Irish guidelines for the use of ACTs for patients 211 
with AECOPD.   212 
Discussion   213 
This was the first study of its kind to examine current practice of physiotherapists in 214 
ROI with respect to ACTs for patients with AECOPD. Results indicate ACTs are 215 
commonly used, and physical activity is perceived to be the most effective ACT. 216 
There appears to be a high degree of uncertainty, however, regarding the evidence 217 
to support this practice and poor awareness of existing national guidelines to support 218 
clinicians regarding this area of practice.    219 
Treatment session duration (5-20 minutes) among physiotherapists from ROI 220 
appears consistent with previous reports [18,19], however the high rate of ACT 221 
prescription (93%) was greater than data from Australia (65%) [18] and Sweden 222 
(75%) [19]. This is despite similarities in the reported prevalence of COPD between 223 
countries. While the relationship between rate of prescription of ACTs and 224 
respondents perceived importance of them was not statistically significant in this 225 
study, an interesting observation between studies using this survey instrument has 226 
been the relationship between perceived importance of ACTs and years working in 227 
cardiorespiratory physiotherapy. As in this study, the Westerdahl et al study [19] did 228 
not report any significant differences in the frequency of prescription of ACTs and 229 
respondents working in cardiorespiratory more or less than 5 years. In Osadnik et als 230 
study [18], however, respondents with less than 5 years experience in 231 
cardiorespiratory reported prescribing ACTs more often than those with greater than 232 
5 years experience (p=0.017). This discrepancy may be reflected in undergraduate 233 
and postgraduate curricula, where more emphasis may be placed on teaching ACTs 234 
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at undergraduate level in Australia. Further research would be warranted and may 235 
reveal some disparity in the delivery of such content internationally.  236 
Just under half of respondents believed there was evidence to support the use of 237 
ACTs during AECOPD. Yet, interestingly, a minority of respondents (36%) reported 238 
they consider the evidence when choosing a suitable ACT. This finding has been 239 
previously observed [18,19] and may reflect a degree of confusion interpreting the 240 
key messages from existing literature. It was concerning to observe the majority of 241 
respondents (71%) were unaware of guidelines published by the Health Services 242 
Executive in ROI [3] in relation to the management of COPD, although these were 243 
only published one month prior to the survey. It would be valuable to examine the 244 
factors contributing to this observation.   245 
While the use of physical activity as an ACT has not yet been directly examined in 246 
people with AECOPD, efficacy data is reported in people with stable cystic fibrosis. A 247 
single exercise session in a small adult CF sample (n=14), FEV1 range 19-108%, 248 
was found to improve ease of sputum clearance [24] and a subsequent study by the 249 
same group [22] (n=24) found PEP and treadmill exercise augmented sputum 250 
clearance equally effectively. The mechanism proposed to explain these findings 251 
suggests PA increases peak expiratory flow and water content of viscous secretions, 252 
thus facilitating clearance. Differences between populations and pathophysiology of 253 
acute exacerbations, however, render it difficult to determine whether such findings 254 
would translate to people with AECOPD. Further enquiry into this area of practice 255 
would be of benefit to clinicians and patients, particularly in light of a recent study 256 
[26] that showed Australian physiotherapists frequently prescribe physical activity for 257 
patients with AECOPD, often in conjunction with huffing and coughing. This survey 258 
also showed referrals to pulmonary rehabilitation after discharge were very high, in-259 
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keeping with Australian guidelines [27] recommending that patients participate in 260 
pulmonary rehabilitation within two weeks of hospital discharge. Data suggests that 261 
pulmonary rehabilitation within 2 weeks after discharge from hospital with AECOPD 262 
can lead to rapid improvements in physical performance, when compared to delayed 263 
rehabilitation post COPD [28]. In ROI, The HSE Model of Care document on 264 
Pulmonary Rehabilitation [3] recommends referral within 3 weeks of hospital 265 
discharge, while The British Thoracic Society [28] advise referring patients on 266 
discharge from hospital and enrolling them in a pulmonary rehabilitation programme 267 
within one month. It would be interesting to speculate whether uptake of physical 268 
activity and/or pulmonary rehabilitation after AECOPD, whilst not typically 269 
implemented for the specific purpose of airway clearance, might accelerate recovery 270 
of issues related to excessive airway secretions. Furthermore, as ‘ease of mastery’ 271 
was cited as an important factor determining choice of specific ACT, it would be 272 
interesting to investigate the patient experience of performing ACTs, including 273 
physical activity, during AECOPD to reveal insights to further guide physiotherapy 274 
prescription.     275 
Limitations   276 
Findings from this survey need to be considered in light of some limitations. It is 277 
difficult to ascertain the precise number of people to whom this survey was 278 
distributed due to ‘snowballing’ recruitment methods and possible overlap of 279 
individuals across multiple dissemination sources and workplace settings. The low 280 
estimated response rate may mean insights lack some generalisability across 281 
broader ROI physiotherapy practice. It would be interesting to speculate whether a 282 
blended method of paper-based and online surveys, and a longer timeframe in which 283 
to conduct the study, might have optimised responses. As we did not record data of 284 
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respondents’ precise work locations, we were also unable to explore the potential for 285 
differences in ACT practice between physiotherapists working in outreach / 286 
integrated care sites and those based in hospitals. This would be useful to ascertain 287 
in future research. Finally, self-reported questionnaires are known to be susceptible 288 
to recall bias, however the nature of questions included in the instrument aimed to 289 
minimise this effect.   290 
Conclusion    291 
Physiotherapists in ROI frequently prescribe ACTs for the management of patients 292 
with AECOPD and perceive physical activity to be the most effective individual 293 
technique despite a lack of evidence to support its rationale for this purpose. 294 
Awareness of national ROI guidelines for the management of COPD was very low 295 
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Figure 1   419 
Figure 1. Frequency of use, perceived effectiveness and perceived ease of patients’ 421 
mastery of airway clearance techniques by physiotherapists in the Republic of 422 
Ireland. For each of frequency, effectiveness and mastery, Likert options were 423 
combined as follows; Frequency; very often or always/often. Effectiveness; very 424 
effective/ effective. Mastery; very easy/easy  425 
PA= physical activity; ACBT= active cycle of breathing techniques; Huff= huffing; Br ex= breathing 426 
exercise; Position = positioning; OPEP 1= oscillating PEP device (Flutter, Acapella, Cornet); Cough= 427 
coughing; Vib M= manual vibration; AD= autogenic drainage; PEP= positive expiratory pressure; MD= 428 
manual drainage; Perc= percussions; SMI= sustained maximal inspiration; OPEP 2= oscillating PEP 429 






Lead authors name; Ciara Hanrahan  434 
Figure 2  435 
Figure 2. Indicators for use of ACTs by physiotherapists in the Republic of Ireland.   437 
Difficulty= difficulty managing secretions; Change= a recent change in sputum characteristics; 438 
IECOPD= clinical signs suggestive of infectious exacerbation; Education= patient in need of 439 
education; Secretions- presence of secretions; Productive= anyone with productive cough; Usual 440 
ACTs= patients who usually perform ACTs as part of management of their condition; >30mls/day= 441 
patients who produce >30mls sputum/day; Other.  442 
 443 
